Get the Stockscreener App
167.74
0.33%
-0.55
After Hours:
167.74
Align Technology Inc stock is traded at $167.74, with a volume of 452.16K.
It is down -0.33% in the last 24 hours and down -0.57% over the past month.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
See More
Previous Close:
$168.29
Open:
$168.29
24h Volume:
452.16K
Relative Volume:
0.40
Market Cap:
$12.01B
Revenue:
$4.10B
Net Income/Loss:
$429.89M
P/E Ratio:
28.13
EPS:
5.9621
Net Cash Flow:
$691.59M
1W Performance:
-4.12%
1M Performance:
-0.57%
6M Performance:
+6.70%
1Y Performance:
-6.95%
1-Day Range:
$166.40
$171.00
1-Week Range:
$160.70
$173.47
52-Week Range:
$122.00
$208.31
Align Technology Inc Stock (ALGN) Company Profile
Name
Align Technology Inc
Sector
Industry
Phone
408-470-1000
Address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA
Compare ALGN vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALGN
Align Technology Inc
|
167.74 | 12.05B | 4.10B | 429.89M | 691.59M | 5.9621 |
ISRG
Intuitive Surgical Inc
|
422.06 | 148.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
151.16 | 41.21B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.81 | 32.47B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
196.04 | 28.19B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.61 | 29.13B | 29.14B | 1.07B | 1.05B | 1.1956 |
Align Technology Inc Stock (ALGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Mar-17-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-09-26 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Oct-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Overweight |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Oct-10-24 | Initiated | Needham | Hold |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-11-23 | Downgrade | Goldman | Neutral → Sell |
| Oct-27-23 | Downgrade | UBS | Buy → Neutral |
| Feb-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jul-28-22 | Downgrade | Goldman | Buy → Sell |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Jan-31-22 | Upgrade | UBS | Neutral → Buy |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-09-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-08-21 | Initiated | Exane BNP Paribas | Outperform |
| Apr-22-21 | Upgrade | Berenberg | Hold → Buy |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-20 | Downgrade | Berenberg | Buy → Hold |
| Jul-20-20 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-24-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-25-19 | Downgrade | Evercore ISI | Outperform → In-line |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Feb-14-19 | Downgrade | UBS | Buy → Neutral |
| Jan-17-19 | Initiated | UBS | Buy |
| Nov-20-18 | Reiterated | Credit Suisse | Outperform |
| Jul-26-18 | Reiterated | Stifel | Buy |
| Jul-13-18 | Reiterated | Stifel | Buy |
| Jun-25-18 | Resumed | BofA/Merrill | Buy |
| May-22-18 | Reiterated | Stifel | Buy |
| May-17-18 | Initiated | Evercore ISI | Outperform |
| Apr-26-18 | Reiterated | Stifel | Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Apr-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-08-18 | Initiated | Barclays | Overweight |
View All
Align Technology Inc Stock (ALGN) Latest News
Align Technology CFO: Global growth, DSOs offset North America demand pressure - MSN
What to expect from Align Technology's Q1 2026 earnings report - MSN
Align Technology Inc. stock (US0162551016): shares firm as investors weigh growth outlook and valuat - AD HOC NEWS
Park State Asset Management's Align Technology Inc(ALGN) Holding History - GuruFocus
Align Technology pitches AI-powered digital dentistry platform beyond Invisalign - MSN
Analysts’ Top Healthcare Picks: Kura Oncology (KURA), Align Tech (ALGN) - The Globe and Mail
What are Wall Street analysts' target price for Align Technology stock? - MSN
Align Technology, Inc. (ALGN) Latest Stock News & Headlines - Yahoo Finance
Align Technology CFO: Global Growth, DSOs Offset North America Demand Pressure - Barchart.com
Is It Too Late to Buy Align Technology Inc (ALGN) After 4.1% Rally? GF Value Says Undervalued - GuruFocus
Is It Too Late to Buy Align Technology Inc (ALGN) After 4.1% Ral - GuruFocus
Align Technology Inc. stock outperforms competitors on strong trading day - MarketWatch
Barclays Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $200 - Moomoo
Assessing Align Technology (ALGN) Valuation After Recent Share Weakness And Mixed Fair Value Signals - simplywall.st
Align Technology Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Align Technology Inc. stock (US0162551016): Nasdaq price consolidates as investors eye Q1 2026 earni - AD HOC NEWS
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
ALGN: AI-powered digital workflows and 3D printing are transforming orthodontic care and patient engagement - TradingView
Align Technology Pitches AI-Powered Digital Dentistry Platform Beyond Invisalign - Yahoo Finance
Align Technology Awards $300,000 In Research Grants To Advance Orthodontic And Dental Research - Pulse 2.0
Align Technology Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
The Technical Signals Behind (ALGN) That Institutions Follow - Stock Traders Daily
Will New Hyderabad Plant Investment Recast Align Technology's (ALGN) Margin and Regional Growth Narrative? - simplywall.st
Align Technology Inc. (ALGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Align Technology Inc. stock underperforms Monday when compared to competitors - MarketWatch
Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research - Business Wire
Align Technology Inc. (ALGN): One of the Top Stocks to Buy According to AI - Insider Monkey
ALGN Technical Analysis & Stock Price Forecast - Intellectia AI
Align Technology, Inc. (ALGN) Stock Analysis: Exploring A 19.50% Upside Potential - DirectorsTalk Interviews
ALGN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Align Technology Inc. stock (US0162551016): Nasdaq price steadies ahead of next earnings window - AD HOC NEWS
Align Technology Inc. stock (US0162551016): shares hold gains after late-May jump on Nasdaq - AD HOC NEWS
Align Technology Inc. stock (US0162551016): shares jump after strong one-day move while valuation st - AD HOC NEWS
Align Technology (ALGN) Down 1.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Align Technology Inc (ALGN) Shares Surge 6.4% -- What GF Score o - GuruFocus
Morgan Stanley Maintains Align Technology(ALGN.US) With Hold Rating, Maintains Target Price $188 - Moomoo
Is Align Technology (ALGN) Now Offering Value After Recent Share Price Rebound - simplywall.st
Agilent Technologies Q2 Earnings Beat Estimates, Revenues Up Y/Y - TradingView
Align Technology Highlights New Invisalign Solutions, Financing and Global Growth - Barchart.com
William Blair Maintains Align Technology(ALGN.US) With Buy Rating - Moomoo
Citi Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $240 - Moomoo
Align Technology (ALGN) Attracts Analyst Attention Amidst Growth Prospects - GuruFocus
Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish at $210 - Insider Monkey
Align Tech to open $200M manufacturing facility in Hyderabad aiming 300+ jobs - Indian Pharma Post
What Are Wall Street Analysts' Target Price for Align Technology Stock? - Yahoo Finance
Leerink Partners Maintains Align Technology(ALGN.US) With Buy Rating, Raises Target Price to $230 - Moomoo
Align Technology Opens First India Manufacturing Facility - Dentistry Today
7 S&P 500 Stocks That Remain on Sale Despite the Index’s Record Highs - Investing.com
Align Tech (ALGN) Gets a Buy from Stifel Nicolaus - The Globe and Mail
Align Technology Inc Stock (ALGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Align Technology Inc Stock (ALGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SIEGEL SUSAN E | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
10,723 |
| Saia Andrea Lynn | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
17,318 |
| Poul Mojdeh | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| Myong Anne | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
9,830 |
| LARKIN C RAYMOND JR | Director |
May 20 '26 |
Option Exercise |
0.00 |
2,326 |
0 |
27,454 |
| Dallas Kevin J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
16,168 |
| LACOB JOSEPH | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
135,916 |
| Conroy Kevin T | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| MORROW GEORGE J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
5,036 |
| Morici John | EVP, CHIEF FINANCIAL OFFICER |
Feb 20 '26 |
Option Exercise |
0.00 |
7,848 |
0 |
16,085 |
8.58%
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):